Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial
Background: Age-related macular degeneration is the leading cause of blindness among elderly individuals in industrialized countries. New drugs and advanced concepts for the treatment of dry AMD (dAMD) are needed. A new approach is the application of intravenous infusions of prostaglandin E1. Object...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 Apr 2013
|
| In: |
Expert opinion on investigational drugs
Year: 2013, Jahrgang: 22, Heft: 7, Pages: 803-812 |
| ISSN: | 1744-7658 |
| DOI: | 10.1517/13543784.2013.794782 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1517/13543784.2013.794782
|
| Verfasserangaben: | Albert J Augustin, Curt Diehm, Frank Grieger & Juergen Bentz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1736257250 | ||
| 003 | DE-627 | ||
| 005 | 20220818235155.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201022s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1517/13543784.2013.794782 |2 doi | |
| 035 | |a (DE-627)1736257250 | ||
| 035 | |a (DE-599)KXP1736257250 | ||
| 035 | |a (OCoLC)1341373052 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Augustin, Albert J. |d 1959- |e VerfasserIn |0 (DE-588)122950186 |0 (DE-627)082253943 |0 (DE-576)169947890 |4 aut | |
| 245 | 1 | 0 | |a Alprostadil infusion in patients with dry age related macular degeneration |b a randomized controlled clinical trial |c Albert J Augustin, Curt Diehm, Frank Grieger & Juergen Bentz |
| 264 | 1 | |c 30 Apr 2013 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.10.2020 | ||
| 520 | |a Background: Age-related macular degeneration is the leading cause of blindness among elderly individuals in industrialized countries. New drugs and advanced concepts for the treatment of dry AMD (dAMD) are needed. A new approach is the application of intravenous infusions of prostaglandin E1. Objective: The aim of this study was to assess efficacy and safety of intravenous alprostadil infusion in patients with dAMD. Methods: This was a prospective, randomized, multi-center study. Patients were treated with intravenous infusion of either 60 µg alprostadil or placebo over 3 weeks. Main efficacy outcomes were mean differences in best corrected visual acuity (BCVA) from baseline assessed in early treatment diabetic retinopathy study (ETDRS) lines immediately, 3 months and 6 months after treatment. Results: In the full analysis set (FAS) a mean difference of 0.89 ± 0.537 ETDRS lines according to analysis of variance-covariance (ANCOVA) resulted in the alprostadil group (n = 16) and a mean difference of -0.05 ± 0.578 in the placebo group (n = 17) 3 months after end of treatment. Thus, effectiveness of alprostadil infusion was numerically superior to placebo treatment by a mean of 0.94 lines after 3 months (1.51 lines after 6 months). These findings were more pronounced in the per protocol set (PPS). Safety results were in line with the good safety profile of alprostadil. Conclusion: A numerical treatment effect in favor of alprostadil was visible, which lasted until the end of follow up. These results provide further evidence that alprostadil probably has a therapeutic effect in the treatment of dAMD and justify further clinical studies. | ||
| 650 | 4 | |a age related macular degeneration | |
| 650 | 4 | |a alprostadil | |
| 650 | 4 | |a prostaglandin E1 | |
| 650 | 4 | |a therapy | |
| 650 | 4 | |a visual acuity | |
| 700 | 1 | |a Diehm, Curt |d 1949- |e VerfasserIn |0 (DE-588)115719105 |0 (DE-627)077426363 |0 (DE-576)16073228X |4 aut | |
| 700 | 1 | |a Grieger, Frank |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bentz, Juergen |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Expert opinion on investigational drugs |d Abingdon, Oxon : Routledge, Taylor & Francis, 1994 |g 22(2013), 7, Seite 803-812 |h Online-Ressource |w (DE-627)324741855 |w (DE-600)2030114-5 |w (DE-576)302969314 |x 1744-7658 |7 nnas |a Alprostadil infusion in patients with dry age related macular degeneration a randomized controlled clinical trial |
| 773 | 1 | 8 | |g volume:22 |g year:2013 |g number:7 |g pages:803-812 |g extent:10 |a Alprostadil infusion in patients with dry age related macular degeneration a randomized controlled clinical trial |
| 856 | 4 | 0 | |u https://doi.org/10.1517/13543784.2013.794782 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201022 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 115719105 |a Diehm, Curt |m 115719105:Diehm, Curt |d 50000 |e 50000PD115719105 |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN1736257250 |e 3784661688 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"pubHistory":["Nachgewiesen 3.1994 -"],"titleAlt":[{"title":"EOID"}],"id":{"zdb":["2030114-5"],"eki":["324741855"],"issn":["1744-7658"]},"part":{"issue":"7","extent":"10","text":"22(2013), 7, Seite 803-812","pages":"803-812","volume":"22","year":"2013"},"physDesc":[{"extent":"Online-Ressource"}],"recId":"324741855","disp":"Alprostadil infusion in patients with dry age related macular degeneration a randomized controlled clinical trialExpert opinion on investigational drugs","origin":[{"dateIssuedKey":"1994","publisherPlace":"Abingdon, Oxon ; London [u.a.]","dateIssuedDisp":"1994-","publisher":"Routledge, Taylor & Francis ; Informa Healthcare"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 03.09.15"],"title":[{"subtitle":"EOID","title":"Expert opinion on investigational drugs","title_sort":"Expert opinion on investigational drugs"}]}],"person":[{"display":"Augustin, Albert J.","family":"Augustin","given":"Albert J.","role":"aut"},{"display":"Diehm, Curt","role":"aut","given":"Curt","family":"Diehm"},{"role":"aut","given":"Frank","family":"Grieger","display":"Grieger, Frank"},{"family":"Bentz","given":"Juergen","role":"aut","display":"Bentz, Juergen"}],"origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"30 Apr 2013"}],"title":[{"title_sort":"Alprostadil infusion in patients with dry age related macular degeneration","title":"Alprostadil infusion in patients with dry age related macular degeneration","subtitle":"a randomized controlled clinical trial"}],"note":["Gesehen am 22.10.2020"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1736257250","physDesc":[{"extent":"10 S."}],"name":{"displayForm":["Albert J Augustin, Curt Diehm, Frank Grieger & Juergen Bentz"]},"id":{"doi":["10.1517/13543784.2013.794782"],"eki":["1736257250"]}} | ||
| SRT | |a AUGUSTINALALPROSTADI3020 | ||